Abstract
Rational emotive behavioral therapy (REBT) is a form of cognitive behavioral therapy developed by Albert Ellis. Developed in the 1950s, REBT was one of the earliest forms of what became known as cognitive behavioral therapy. It was successfully adapted for children and adolescents in the 1980s (Barnard & Joyce, 1984) and has been studied extensively and shown to be effective in this population (Gonzales, Nelson, & Gutkin, 2004). This article provides a selective review of the literature, and brief overview of REBT, and discusses its advantages and disadvantages.
Keywords: Rational emotive behavioral therapy, Albert Ellis, children and adolescents, review, neurotic behaviors, maladaptive, supportive therapy, psychoanalytically-oriented therapy, Alzheimer's disease
Adolescent Psychiatry
Title: Albert Ellis Rational-Emotive Behavior Therapy
Volume: 1 Issue: 1
Author(s): Richard Rosner
Affiliation:
Keywords: Rational emotive behavioral therapy, Albert Ellis, children and adolescents, review, neurotic behaviors, maladaptive, supportive therapy, psychoanalytically-oriented therapy, Alzheimer's disease
Abstract: Rational emotive behavioral therapy (REBT) is a form of cognitive behavioral therapy developed by Albert Ellis. Developed in the 1950s, REBT was one of the earliest forms of what became known as cognitive behavioral therapy. It was successfully adapted for children and adolescents in the 1980s (Barnard & Joyce, 1984) and has been studied extensively and shown to be effective in this population (Gonzales, Nelson, & Gutkin, 2004). This article provides a selective review of the literature, and brief overview of REBT, and discusses its advantages and disadvantages.
Export Options
About this article
Cite this article as:
Rosner Richard, Albert Ellis Rational-Emotive Behavior Therapy, Adolescent Psychiatry 2011; 1 (1) . https://dx.doi.org/10.2174/2210676611101010082
DOI https://dx.doi.org/10.2174/2210676611101010082 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neurological Disorders of Purine and Pyrimidine Metabolism
Current Topics in Medicinal Chemistry Metabolic Syndrome X is a Low-Grade Systemic Inflammatory Condition with its Origins in the Perinatal Period
Current Nutrition & Food Science Molecular Imaging to Monitor Repair of Myocardial Infarction Using Genetically Engineered Bone Marrow-Derived Mesenchymal Stem Cells
Current Gene Therapy The Use of Proteomics to Study Infectious Diseases
Infectious Disorders - Drug Targets Discovery and Pre-clinical Development of Antithrombotics from Hematophagous Invertebrates
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Recent Applications of Artificial Intelligence in Early Cancer Detection
Current Medicinal Chemistry Obstetrician-Gynecologists’ Practices, Statistical Literacy, and Risk Communication with Regard to Sexually Transmitted Infections
Current HIV Research Carbohydrates and Epithelial Repair - More Than Just Post-Translational Modification
Current Drug Targets Involvement of Uridine-Nucleotide-Stimulated P2Y Receptors in Neuronal Growth and Function
Central Nervous System Agents in Medicinal Chemistry An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: A Review
Current Drug Delivery Medicinal Chemistry of Hsp90 Inhibitors
Current Topics in Medicinal Chemistry From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies
Current Pharmaceutical Design Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances
Current Molecular Pharmacology The Centrosome: A Target for Cancer Therapy
Current Cancer Drug Targets Immunomodulation in Polytrauma and Polymicrobial Sepsis - Where Do We Stand?
Recent Patents on Inflammation & Allergy Drug Discovery Meet Our Editorial Board Member:
Current Cancer Therapy Reviews Clinical Experience with Antiangiogenic Therapy in Leukemia
Current Cancer Drug Targets The Role of Co-Infections in Mother-to-Child Transmission of HIV
Current HIV Research Immunomodulators: Friends or Enemies in Surgery for Crohn’s Disease?
Current Drug Targets